GlaxoSmithKline was a result of the merger of Glaxo Wellcome and SmithKline Beecham.
Image: company logo
Headquartered in Brentford, London the company has a total 96,575 employees, and the company was founded in 2000. Sir Beecham Group was founded in 1843, and it started its operations by producing laxatives.
Philip Hampton serves as the Chairman of the company while Andrew Witty is the CEO of the company.
Andrew Witty will retire from his post in 2017. GlaxoSmithKline is active in mainly 3 industries - Pharmaceutical, Biotechnology and Consumer goods.
The company was charged with promotion of anti-depressants for uses which were unapproved. It paid a fine of $3 billion for these charges in July 2012. GSK is not much involved in the production of treatment for cancer and rare diseases. It follows the principle that high priced drugs are not sustainable in United States. Most of the big pharmaceutical companies are investing heavily in developing the treatment of rare diseases, GSK has shut down its R&D in treatment of rare diseases. In 2014, GSK sold its cancer drug business to Novartis in return of Novartis' consumer health care and vaccine business. The company had a revenue of $ 27206.91 million in 2015. Its total profits were $ 9521.22 million. The market capitalization of the company was at $ 99600 million.